Painful Sex After Menopause: The Treatable Part
It is one of the most common symptoms of menopause and the one least often mentioned to a clinician. Around half of postmenopausal women have it to some degree. Most assume it is permanent, or a problem of desire, or simply what happens now. It is usually none of those. It is a tissue problem, and the tissue can be restored.
This page is about pain — not desire, which is covered on our low libido pages, and which is a different problem with different causes even when the two arrive together. Estriol vaginal cream is the treatment this page leads to.
What is actually happening
The vagina and vulva are estrogen-dependent tissues. With estrogen, the vaginal wall is thick, folded, elastic and well supplied with blood; it lubricates on arousal and stretches without tearing. As estrogen falls, over the years around menopause, the wall thins to a few cell layers, loses its folds, becomes pale, dry and fragile, and lubricates less and later. The opening can narrow. Small tears happen with friction, and heal slowly.
Sex on that tissue hurts — at entry, with friction, sometimes for hours afterwards as a burning that outlasts the act. Bleeding after sex is common and alarming. And because pain teaches avoidance, the pelvic-floor muscles learn to tense in anticipation, which makes the next attempt hurt more. The cycle is physical at both ends.
This is genitourinary syndrome of menopause — the term that replaced "vaginal atrophy" a decade ago, partly because women were not, understandably, going to raise something called atrophy.
What local estrogen does
Applied to the tissue, estrogen reverses the thinning. The wall thickens, the folds return, blood supply and lubrication recover, the pH normalizes. It does this at the tissue itself, with minimal absorption into the body — which is why it needs no progesterone, is outside the timing window that governs systemic therapy, and is usable by women for whom systemic estrogen is not.
The evidence is old, consistent and strong: vaginal estrogen improves dryness, pain with sex and the physical measures of tissue health in randomized trials, and it is the first-line pharmacological treatment for moderate-to-severe symptoms in every major guideline.
Improvement in dryness and irritation usually comes within weeks. Comfort with sex takes longer — the tissue has to rebuild, and the learned tension has to unlearn. Most women who are going to respond have responded well within three months.
What local estrogen does not fix, and who else helps
Pelvic-floor tension. Where months of pain have taught the muscles to guard, restoring the tissue is necessary and not sufficient. A pelvic-floor physiotherapist — a specialist who exists in most cities and is underused everywhere — treats the muscular half. We refer; see the bladder and pelvic floor page.
Skin conditions. Lichen sclerosus and similar vulval skin disorders cause pain, tearing and a pale, fragile appearance that can look like estrogen loss and is not. They need a dermatologist or a gynecologist with a vulval-disease interest, and the wrong treatment delays the right one. Persistent itching, white patches or architectural change in the vulva is a reason to be examined, not treated remotely.
Deep pain. Pain felt deep in the pelvis on penetration, rather than at the entrance, has a different list of causes — endometriosis, fibroids, prolapse, adhesions — and needs a gynecological examination.
Desire. Restoring comfort often restores interest, because pain is a powerful suppressant of desire. Where it does not, that is the separate conversation on the low libido page.
We screen for all four in the history. Where any is present, the referral comes first or alongside; local estrogen can still be started where it is appropriate.
Systemic HRT and this symptom
A woman on a patch or an oral estrogen for flushes may find her dryness improves only partly, or not at all. That is expected. Systemic estrogen reaches the vaginal tissue, but at a lower concentration than a local product, and many women on systemic therapy still need local treatment — see estradiol cream vs vaginal estrogen for the distinction. The two are used together without difficulty.
Frequently asked questions
Loss of estrogen thins and dries the vaginal wall, reduces elasticity and lubrication, and makes the tissue fragile. Pain then teaches the pelvic muscles to tense, which adds to it.
Yes — it is the first-line treatment in every major guideline, with consistent randomized-trial evidence. Dryness improves within weeks; comfort with sex usually within about three months.
It is common with thinned tissue, but any postmenopausal bleeding should be evaluated by a clinician to rule out other causes before it is attributed to dryness.
Systemic estrogen reaches the vaginal tissue at lower concentration than a local product. Many women on HRT also need vaginal estrogen.
Regular vaginal moisturizers, a good lubricant for sex, and pelvic-floor physiotherapy where the muscles have learned to guard. These work alongside estrogen, not instead of it.
Deep pelvic pain, persistent itching, white patches or visible skin changes need examination — those point to conditions local estrogen does not treat.
Where this fits in your plan
The Estriol Vaginal Cream page covers the product. If bleeding, deep pain or skin changes are part of the picture, examination comes first; otherwise the assessment is where this starts.
We measure first. Then we act.
References
- The Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement. Menopause 2020;27:976–992.
- Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology. Menopause 2014;21:1063–1068.
- Lethaby A et al. Local estrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2016.
- ACOG Practice Bulletin No. 141 / Clinical Practice Guideline on management of menopausal symptoms — genitourinary section.
- Kingsberg SA et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE survey. Journal of Sexual Medicine 2013;10:1790–1799 — prevalence and under-reporting.
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Postmenopausal bleeding should always be evaluated in person.